Parsons Capital Management Inc Novartis Ag Transaction History

Parsons Capital Management Inc

  • $1.55 Billion
  • Q3 2024

A detailed history of Parsons Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Parsons Capital Management Inc holds 14,816 shares of NVS stock, worth $1.57 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
14,816
Previous 15,001 1.23%
Holding current value
$1.57 Million
Previous $1.6 Million 6.7%
% of portfolio
0.11%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
SELL
$106.13 - $120.89 $19,634 - $22,364
-185 Reduced 1.23%
14,816 $1.7 Million
Q2 2024

Jul 19, 2024
SELL
$92.57 - $107.37 $101,271 - $117,462
-1,094 Reduced 6.8%
15,001 $1.6 Million
Q1 2024

Apr 22, 2024
SELL
$95.27 - $108.47 $96,603 - $109,988
-1,014 Reduced 5.93%
16,095 $1.56 Million
Q4 2023

Jan 22, 2024
SELL
$92.27 - $101.54 $84,427 - $92,909
-915 Reduced 5.08%
17,109 $1.73 Million
Q3 2023

Nov 06, 2023
SELL
$94.73 - $105.13 $4,262 - $4,730
-45 Reduced 0.25%
18,024 $1.84 Million
Q2 2023

Aug 04, 2023
BUY
$92.52 - $104.91 $17,486 - $19,827
189 Added 1.06%
18,069 $1.82 Million
Q1 2023

Apr 17, 2023
SELL
$80.03 - $92.81 $342,208 - $396,855
-4,276 Reduced 19.3%
17,880 $1.64 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $67,239 - $82,342
-890 Reduced 3.86%
22,156 $2.01 Million
Q3 2022

Oct 26, 2022
SELL
$74.61 - $87.26 $236,439 - $276,526
-3,169 Reduced 12.09%
23,046 $1.75 Million
Q2 2022

Jul 29, 2022
SELL
$80.52 - $93.75 $85,592 - $99,656
-1,063 Reduced 3.9%
26,215 $2.22 Million
Q1 2022

May 02, 2022
SELL
$80.11 - $90.62 $25,074 - $28,364
-313 Reduced 1.13%
27,278 $2.39 Million
Q4 2021

Feb 07, 2022
BUY
$79.7 - $88.13 $107,834 - $119,239
1,353 Added 5.16%
27,591 $2.41 Million
Q3 2021

Nov 09, 2021
SELL
$81.78 - $95.14 $285,657 - $332,324
-3,493 Reduced 11.75%
26,238 $2.15 Million
Q2 2021

Aug 03, 2021
BUY
$85.24 - $94.15 $214,378 - $236,787
2,515 Added 9.24%
29,731 $2.71 Million
Q1 2021

Apr 28, 2021
SELL
$83.5 - $98.47 $200,817 - $236,820
-2,405 Reduced 8.12%
27,216 $2.33 Million
Q4 2020

Feb 08, 2021
BUY
$78.07 - $94.43 $177,843 - $215,111
2,278 Added 8.33%
29,621 $2.8 Million
Q3 2020

Oct 29, 2020
SELL
$82.14 - $91.0 $170,933 - $189,371
-2,081 Reduced 7.07%
27,343 $2.38 Million
Q2 2020

Aug 10, 2020
BUY
$80.93 - $91.1 $182,335 - $205,248
2,253 Added 8.29%
29,424 $2.57 Million
Q1 2020

May 05, 2020
SELL
$70.67 - $99.01 $86,500 - $121,188
-1,224 Reduced 4.31%
27,171 $2.24 Million
Q4 2019

Feb 03, 2020
SELL
$84.35 - $95.37 $19,737 - $22,316
-234 Reduced 0.82%
28,395 $2.69 Million
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $33,617 - $37,044
393 Added 1.39%
28,629 $2.49 Million
Q2 2019

Aug 01, 2019
BUY
$75.4 - $92.8 $829 - $1,020
11 Added 0.04%
28,236 $2.58 Million
Q1 2019

Apr 26, 2019
BUY
$75.32 - $86.15 $27,190 - $31,100
361 Added 1.3%
28,225 $2.71 Million
Q4 2018

Feb 01, 2019
BUY
$73.66 - $82.02 $16,057 - $17,880
218 Added 0.79%
27,864 $2.39 Million
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $12,986 - $15,021
194 Added 0.71%
27,646 $2.38 Million
Q2 2018

Aug 09, 2018
BUY
$64.91 - $73.36 $24,990 - $28,243
385 Added 1.42%
27,452 $0
Q1 2018

May 07, 2018
SELL
$70.39 - $84.15 $88,269 - $105,524
-1,254 Reduced 4.43%
27,067 $2.19 Million
Q4 2017

Feb 02, 2018
BUY
$72.33 - $77.64 $940 - $1,009
13 Added 0.05%
28,321 $2.38 Million
Q3 2017

Oct 26, 2017
BUY
$74.14 - $77.27 $2.1 Million - $2.19 Million
28,308
28,308 $2.43 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $228B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Parsons Capital Management Inc Portfolio

Follow Parsons Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Parsons Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email